Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Optimal timing for stent replacement in malignant biliary tract obstruction

J T Frakes¹, J F Johanson, J J Stake

¹Department of Medicine, University of Illinois College of Medicine, Rockford.

Gastrointestinal Endoscopy

|March 1, 1993

Summary

Prophylactic endoscopic stent replacement for malignant biliary obstruction can be safely extended from 3 to 6 months. This change reduces patient discomfort and costs, while avoiding unnecessary procedures for those with shorter survival times.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.

Alimentary pharmacology & therapeutics·2012

Same author

Computer-assisted analysis of abrasive transepithelial brush biopsies increases the effectiveness of esophageal screening: a multicenter prospective clinical trial by the EndoCDx Collaborative Group.

Digestive diseases and sciences·2010

Same author

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study.

Alimentary pharmacology & therapeutics·2010

Same author

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

Alimentary pharmacology & therapeutics·2008

Same author

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.

Alimentary pharmacology & therapeutics·2008

Same author

Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.

Alimentary pharmacology & therapeutics·2007

Area of Science:

Gastroenterology
Oncology
Palliative Care

Background:

Malignant biliary tract obstruction is often treated with endoscopic stent placement.
Stent occlusion is a common complication, leading to discussions about prophylactic replacement intervals.

Purpose of the Study:

To evaluate the safety and efficacy of extending the prophylactic stent replacement interval for malignant biliary strictures from 3 to 6 months.
To analyze occlusion rates, clinical response, and survival in patients undergoing stent placement.

Main Methods:

Retrospective analysis of 70 stents placed in 50 patients with malignant biliary strictures.
Patients received 10F or 11.5F stents.
Data collected included clinical response, stent occlusion rates at 3 and 6 months, and survival.

Related Experiment Videos

Main Results:

Obstructive symptoms resolved in 94% of patients.
Stent occlusion rates at 3 months (4.2%) and 6 months (10.8%) were not significantly different.
Median overall survival was 22 weeks, with poorer outcomes in patients with metastatic cancer.

Conclusions:

Extending the prophylactic stent replacement interval to 6 months is safe and feasible.
This extended interval can decrease patient discomfort, reduce healthcare costs, and avoid procedures in patients with limited survival.